Abstract
Background One third of women experience IPV and potential sequelae. Sustainable Development Goal (SDG) 5.2—to eliminate all violence against women, including IPV— compels national governments to monitor such violence. We conducted the first global measurement-invariance assessment of standardized physical IPV items.
Methods Thirty-six Demographic and Health Surveys (DHS) from 36 Lower-/Middle-Income Countries (LMICs) administering the same 18 IPV items during 2012-2018 were included. We performed exploratory and confirmatory factor analyses (EFA/CFA) with seven physical IPV items, which are the most behaviorally specific and reliable. Datasets meeting EFA/CFA model fit criteria (loadings>.35, RMSEA<.08, CFI/TLI>.95) were included in multiple-group CFA to test strict measurement invariance, and in alignment optimization (AO) to test approximate measurement invariance. We compared national rankings based on AO-derived scores and lifetime physical IPV prevalences, and correlated AO-dervied scores with physical, sexual, and psychological IPV prevalences.
Results Estimated lifetime physical IPV varied widely (5.6%-50.5%). All loadings and fit statistics met thresholds in country-specific EFA/CFAs. A unidimensional, seven-item physical IPV construct lacked scalar invariance in multiple-group CFA but achieved approximate measurement invariance in AO analysis, as 12.3% (<25%) of model parameters were non-invariant. National rankings of AO-derived scores and estimated physical IPV prevalences were similarly distributed, but national estimates often were not significantly different, so grouped score ranges or prevalence ranges are advised. Three items (slap, twist, choke) warrant cognitive testing to improve their psychometric performance. Correlations of AO-derived scores with IPV prevalences ranged from .48 to .66.
Conclusions Seven DHS physical-IPV items were approximately invariant across 36 LMICs spanning five regions and are reasonable for cross-national, grouped comparison of physical IPV. Measurement-invariance testing over time will inform their utility to monitor SDG5.2.1; cross-national and cross-time measurement-invariance testing of other IPV item sets is warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health R01HD099224 (PIs CJC, KMY).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Emory University determined the study to be exempt from IRB review, as the data analyzed in the study are fully de-identified, publicly available datasets and no one involved in the original studies is engaged in the research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from the Demographic and Health Surveys (DHS) are publicly available upon reasonable request to Measure DHS: https://dhsprogram.com/data/new-user-registration.cfm. Investigators must request from Measure DHS access to the data used in this analysis.
